Melanotan II: pilot-study regimen
Human schedule
Melanotan II is given by subcutaneous injection (typically into the abdominal fat pad). The figures below are a generalized reference drawn from early clinical studies and described protocols.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Loading period (2–3 weeks) | 0.25–0.5 mg per day | Starting dose (often begun at 0.25 mg) |
| Maintenance period | 0.5–1 mg, 1–2x weekly | Increase if needed |
| Upper limit | up to 2 mg per day | Maximum in this schedule |